Oncology Drugs Flashcards
Cancer Drugs Targeting Nucleotide Synthesis
MTX, 5-FU (thymidine synthesis)
6-MP (de novo purine synthesis)
Hydroxyurea (inhibits ribonucleotide reductase)
Cancer Drugs Targeting DNA
Crosslink DNA: alkylating agents, cisplatin
DNA strand breaks: Bleomycin
Intercalate DNA: Dactinomycin, doxorubicin
Topo II inhibitor: Etoposide
Topo I inhibitor: Irinotecan
Cancer Drugs Targeting Cell Division
Vinca alkaloids: inhibit microtubule formation
Paclitaxel; inhibits microtubule disassembly
Cell Cycle Independent Drugs
Platinum agents (cisplatin) Alkylating agents (busulfan, cyclophosphamide, ifosfamide, nitrosoureas (carmustine))
Antimetabolites (S phase specific - DNA synthesis)
Azathioprine, cladribine, cytarabine, 5-FU, hydroxyurea, methotrexate, 6-MP
Topoisomerase Inhibitors (inhibits S -DNA synthesis & G2 - repair checkpoint)
Etoposide, Teniposide, Irinotecan, Topotecan
G2 phase specific - repair checkpoint
Bleomycin
Microtubule Inhibitors (M phase specific)
Paclitaxel, Vinblastine, Vincristine
Azathioprine, 6-mercaptopurine
Purine (thiol) analogs (inhibit de novo synthesis)
Activated by HGPRT; Azathioprine is metabolized into 6-MP
CU: prevent organ rejection, RA, IBD, SLE, weaning off steroids in chronic dz, Tx steroid-refractory chronic dz
AE: myelosuppression, GI, liver
Metabolized by xanthine oxidase = increased toxicity with allopurinol or febuxostat
Cladribine
Purine analog w/multiple mechanisms:
inhibits DNA pol & DNA strand breaks
CU: Hairy cell leukemia
AE: Myelosuppression, nephrotoxic & neurotoxic
Cytarabine (arabinofuranosyl cytidine)
Pyrimidine analog - inhibits DNA pol
CU: Leukemias (AML), lymphomas
AE: Myelosuppression w/megaloblastic anemia
CYTarabine causes panCYTopenia
5-fluorouracil
Pyrimidine analog bioactivated to 5-FdUMP - covalently complexes folic acid and then inhibits thymidylate synthase (decreases dTMP / DNA synthesis)
EFFECTS ENHANCED w/LEUCOVORIN (folinic acid)
CU: colon & pancreatic cancer, topical for basal cell carcinoma
AE: myelosuppression - worse w/leucovorin
Methotrexate
Folic acid analog - competitively inhibits dihydrofolate reductase (decreases dTMP / DNA synthesis)
CU: Cancers: leukemias (ALL), lymphomas, chorioca, sarcoma. Non-neoplastic: ectopic pregnancy, abortion (w/misoprostol), RA, psoriasis, IBD, vasculitis
AE: Myelosuppression; reversible w/leucovorin “rescue”
Hepatotoxic, mucositis (mouth ulcers), pulmonary fibrosis
Anti-tumor Antibiotics
Bleomycin, Dactinomycin (actinomycin D), Doxorubicin, Daunorubicin
Alkylating Agents
Busulfan, Cyclophosphamide/ifosfamide, Nitrosureas (carmustine, lomustine, semustine, streptozocin)
Microtubule Inhibitors
Paclitaxel (other taxols), Vincristine, Vinblastine
Bleomycin
Induces free radical formation - breaks in DNA strands
CU: testicular cancer, Hodgkin lymphoma
AE: pulmonary fibrosis, skin hyperpigmentation, minimal myelosuppression